sacituzumab govitecan
gilead sciences
['tropics-02', 'trodelvy', '$gild']
$gild tropics-02 abstract is out: mpfs of 5.5 mos for trodelvy vs 4.0 mos for chemo, for a 34% risk reduction. can anything be salvaged here? my first take via : (#asco22 press conference in one hour)
Pharma and biotech reporter, found a home at Evaluate Vantage.